Skip to content
Screener

Bausch + Lomb BLCO Q4 2025 Annual earnings

Reported February 18, 2026 · Before market open

Revenue$1.4BBeat by $19.7M
EPS$0.32Miss by $0.03
Revenue estimate$1.4B
EPS estimate$0.35

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$1.4B
EPS estimate$0.21

Financials

Q4 2025

Income statement

See full
Revenue$1.4B+9.8%
Operating income$112.0M+28.7%
Net income-$58.0M-1,833%
EPS (diluted)-$0.17-1,600%

Balance sheet

See full
Cash & equivalents$397.0M+25.6%
Total debt$5.2B+5.6%
Total equity$6.4B-0.4%
Total assets$14.0B+4.1%

Cash flow

See full
Operating cash flow$136.0M+518%
CapEx$76.0M-17.4%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$6.05B-4.9%
Enterprise value$10.86B-1.1%
P/S1.2×-0.1×

Profitability

See full
Operating margin2.2%-1.2pp
Net margin-7.1%+0.5pp

Returns & leverage

See full
Return on equity-5.6%+1.1pp
Debt / equity0.8×0.0×
Current ratio1.6×-0.1×

Segments

By segment

See full
Vision Care$778.0M+7.6%
Pharmaceuticals$319.0M+19.0%
Surgical$249.0M+7.8%

By product

See full
Devices$518.0M+8.8%
OTC$490.0M+6.1%
Branded and Other Generics$71.0M+2.9%

FAQ

When did Bausch + Lomb report Q4 2025 earnings?
Bausch + Lomb (BLCO) reported Q4 2025 earnings on February 18, 2026 before market open.
What were Bausch + Lomb's Q4 2025 revenue and EPS?
Bausch + Lomb reported revenue of $1.4B and eps of $0.32 for Q4 2025.
Did Bausch + Lomb beat estimates in Q4 2025?
Revenue beat the consensus estimate of $1.4B by $19.7M. EPS missed the consensus estimate of $0.35 by $0.03.
How did Bausch + Lomb's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.8% from $1.3B a year earlier and eps grew 28.0% from $0.25.
Where can I find Bausch + Lomb's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001860742-26-000006) and the 10-K periodic report (0001860742-26-000007) directly on SEC EDGAR. The filing index links above go to sec.gov.